| Companies sponsors |
AstraZeneca (dapagliflozin) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Kidney Care UK |
| |
Kidney Patient Involvement Network |
| |
Kidney Research UK |
| |
National Kidney Federation |
| |
Polycystic Kidney Disease Charity |
| |
South Asian Health Foundation |
| |
Specialised Healthcare Alliance |
| Professional groups |
Association of Renal Industries |
| |
Association of Renal Technologists |
| |
British Association of Urological Nurses |
| |
British Geriatrics Society |
| |
Royal College of General Practitioners |
| |
Royal College of Nursing |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal Pharmaceutical Society |
| |
Royal Society of Medicine |
| |
Society for DGH Nephrologists |
| |
UK Clinical Pharmacy Association |
| |
UK Kidney Association |
| |
UK Renal Pharmacy Group |
| Associated public health groups |
Public Health Wales |
| |
UK Health Security Agency |
| Comparator companies |
Boehringer Ingelheim (empagliflozin) |
| General commentators |
All Wales Therapeutic and Toxicology Centre |
| |
Allied Health Professionals Federation |
| |
Board of Community Health Councils in Wales |
| |
British National Formulary |
| |
Care Quality Commission |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare Products Regulatory Agency |
| |
National Association of Primary Care |
| |
National Pharmacy Association |
| |
NHS Alliance |
| |
NHS Confederation |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Centre for Kidney Research and Innovation |
| |
Cochrane Kidney and Transplant Group |
| |
Genomics England |
| |
MRC Clinical Trials Unit |
| |
National Institute for Health & Care Research |